Prexton Therapeutics Series B financing round raises €29 million ($31M) to advance its novel Parkinson’s therapeutic


Prexton Therapeutics Series B financing round raises €29 million ($31M) to advance its novel Parkinson’s therapeutic

Forbion & Seroba co-led funding, forming international consortium of Merck Ventures, Ysios and Sunstone

Funding to finance two Phase II trials in Parkinson’s disease

Download the PDF